Sun , May 29, 2022
iLAVA Entourage
Home / World Cannabis News / Low-THC Cannabis Leads to Reduced Use of Prescription Drugs

Low-THC Cannabis Leads to Reduced Use of Prescription Drugs

Italy Cannabis

According to a new report based on data from Italy’s medical marijuana program, Italians’ access to high-CBD/low-THC cannabis products caused a direct decrease in prescription drug consumption.

The report assessed adults’ access to high-CBD/low-THC (below 0.6% THC) marijuana products and prescription drug sales in 106 Italian provinces over two years, NORML reported.

“We find that the local availability of light cannabis (low-THC, CBD-based products) led to a significant decrease in the number of dispensed boxes of anxiolytics by approximately 11.5%, a reduction of dispensed sedatives by 10% and a reduction of dispensed anti-psychotics by 4.8%,” the report states.

The report also found that Italians’ access to high-CBD/low-THC cannabis resulted in minor decreases in the use of prescription anti-depressants, anti-epileptics, opioids, and migraine drugs.

The report “represents the first-ever evidence from Europe on the substitution effects induced by a compound of cannabis, CBD,” the authors wrote. “As the product is increasingly available in other …. Countries, our results provide relevant implications for policymakers.”

Arizona Cannabis News and Info

AZ Cannabis Updates

About William Wallace

is a veteran writer in the legalized cannabis industry. Contact William here.